Organogenesis Holdings (ORGO) Income Statement: Revenue & Earnings

Organogenesis Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Organogenesis Holdings Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	482.04	433.14	450.89	467.36	338.30	260.98	193.45
Cost of Revenue	115.74	106.48	105.02	114.20	87.32	75.95	68.81
Gross Profit	366.30	326.66	345.87	353.16	250.98	185.03	124.64
Operating Expenses
Research & Development	50.27	44.38	39.76	30.74	20.09	14.80	10.74
Selling, General & Administrative	294.51	269.75	283.81	250.20	203.37	199.69	161.96
Operating Expenses	367.59	314.13	323.57	280.94	223.46	214.49	172.70
Operating Income	-1.28	12.53	22.30	72.22	27.52	-29.46	-48.06
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.06
Interest Expense	1.54	2.19	2.01	7.24	-11.28	0.00	10.79
Other Income/Expense	-1.52	0.06	-0.01	-1.90	0.10	1.85	-5.90
Income
Income Before Tax	-2.81	10.39	20.28	63.09	17.76	-40.30	-64.75
Income Tax Expense	-3.67	5.45	4.75	-31.12	0.53	0.15	0.08
Net Income	0.86	4.95	15.53	94.20	17.23	-40.45	-64.83
Net Income - Continuous Operations	0.86	4.95	15.53	94.20	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	15.76	27.95	33.02	87.00	35.70	-21.88	-46.98
EBIT	-2.61	12.58	22.29	70.32	27.52	-31.31	-53.96
Depreciation & Amortization	17.03	15.37	10.73	16.68	8.18	3.39	0.00
Earnings Per Share
Basic EPS	-	-	-	1.00	-	-	-1.00
Diluted EPS	-	-	-	1.00	-	-	-1.00
Basic Shares Outstanding	131.67	131.23	130.07	128.33	107.74	92.84	69.32
Diluted Shares Outstanding	131.67	132.75	132.38	133.66	111.36	0.00	69.32